Depression News and Research

Latest Depression News and Research

Genetic variations in one serotonin receptor could be the reason behind psychedelic treatment disparity

When all else fails, some patients trying to overcome alcoholism, severe depression or anxiety, and even cluster headaches, turn to psychedelic drugs, which clinical research has shown can help treat individuals with these conditions, sometimes with dramatically positive results.

27 Jul 2022

Study reveals why service dogs may improve mental health for some veterans with PTSD

A new analysis dives into the use of service dogs by U.S. veterans who have posttraumatic stress disorder (PTSD), illuminating factors and mechanisms that may underlie the mental health effects of these relationships.

27 Jul 2022

UK study finds over 100 symptoms of long COVID in non-hospitalized adults

In a new study, researchers determined symptoms and risk factors present beyond 12 weeks in non-hospitalized adults with confirmed SARS-CoV-2 infection.

27 Jul 2022

Genetic variations in serotonin receptor causes different response to psychedelic drugs

Cluster headaches, anxiety and depression can be debilitating for people living with these conditions. Psychedelic drugs have shown benefits as treatments for these conditions in clinical studies, but not for everyone.

27 Jul 2022

PCORI approves $258 million funding to support 26 new health care-related studies

The Patient-Centered Outcomes Research Institute has approved funding awards totaling $258 million to support 26 new research studies.

26 Jul 2022

Experts call for consistent measurement across the social determinants of health

Access to quality healthcare depends on the accurate evaluation of social determinants of health (SDOH), but the healthcare industry has placed insufficient effort on this according to the authors of a new Commentary. The Commentary, titled "A Call for Consistent Measurement Across the SDOH Industry Landscape," is published in the peer-reviewed journal Population Health Management.

26 Jul 2022

Study shows the efficacy of Yoga of Immortals mobile app for urinary incontinence

People with loss of urinary control who used the Yoga of Immortals mobile app – a globally used app that combines specific yogic postures in the Sanatan tradition with breathing exercises, sound therapy and meditation – found significant improvement in the frequency and severity of urine leaks at four weeks of practice, according to a Rutgers study.

26 Jul 2022

$50 million PCORI funding approved for studies focused on treating suicidal depression and bipolar depression

Research teams at Mass General Brigham's founding members, Brigham and Women's Hospital and Massachusetts General Hospital, have been approved for more than $50 million in funding awards by the Patient-Centered Outcomes Research Institute for studies focused on treating two important mental health conditions.

26 Jul 2022

Poll: Many older adults use integrative medicine strategy to ease physical or mental health symptoms

Nearly 40% of older adults currently use at least one integrative medicine strategy to try to ease symptoms of a physical or mental health issue, or to help them relax, a new poll finds.

26 Jul 2022

People who use high potency cannabis more likely to experience addiction, psychotic disorder

As the strength or potency of cannabis products has increased internationally over the years, so have rates of people being treated for cannabis addiction, say the authors of a new study.

26 Jul 2022

Religious leaders can be effective change agents for reducing intimate partner violence

Intimate partner violence - or abuse and aggression in a romantic relationship - is a pervasive global issue. In Uganda, a primarily Christian country in East Africa, 56% of women who've been married report being sexually violated by a current partner.

25 Jul 2022

Dental health care workers report anxiety and depression symptoms during peaks of the pandemic

The first known U.S. study to evaluate the mental health of frontline dentists and dental hygienists during the pandemic found that dental health care workers report anxiety and depression symptoms during peaks of transmission among the public.

25 Jul 2022

What is the role of psychedelic drugs in the treatment of psychiatric disorders?

A new study aimed to determine the clinical applications of psychedelic drugs along with psychedelic-assisted therapy for different psychiatric disorders.

25 Jul 2022

High-dose supplementation of Vitamin B6 decreases anxiety

Researchers reported that vitamin B6 supplementation reduced anxiety.

25 Jul 2022

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

AbbVie today announced it has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.

From AbbVie 21 Jul 2022

Research highlights the impact of social determinants of health on hypertension control

A research article published this month in the Mayo Clinic Proceedings highlights the significant impact of social determinants of health on patients' ability to sustain control of hypertension.

20 Jul 2022

Wearable activity trackers are effective in increasing physical activity and improving health

New findings from Australian researchers have endorsed what millions of people around the world believe: fitness trackers, pedometers and smart watches motivate us to exercise more and lose weight.

20 Jul 2022

Review: No clear evidence that serotonin levels are responsible for depression

After decades of study, there remains no clear evidence that serotonin levels or serotonin activity are responsible for depression, according to a major review of prior research led by UCL scientists.

20 Jul 2022

Fatigue in long covid patients linked to anxiety, depression, and apathy

The most common symptoms of the post-COVID-19 condition known aslong covidinclude fatigue, shortness of breath and cognitive dysfunction, according to the World Health Organization (WHO).

20 Jul 2022

High-dose Vitamin B6 tablets could reduce feelings of anxiety and depression

Taking high-dose Vitamin B6 tablets has been shown to reduce feelings of anxiety and depression by new research.

19 Jul 2022

Depression News and Research

Latest Depression News and Research

Genetic variations in one serotonin receptor could be the reason behind psychedelic treatment disparity

Study reveals why service dogs may improve mental health for some veterans with PTSD

UK study finds over 100 symptoms of long COVID in non-hospitalized adults

Genetic variations in serotonin receptor causes different response to psychedelic drugs

PCORI approves $258 million funding to support 26 new health care-related studies

Experts call for consistent measurement across the social determinants of health

Study shows the efficacy of Yoga of Immortals mobile app for urinary incontinence

$50 million PCORI funding approved for studies focused on treating suicidal depression and bipolar depression

Poll: Many older adults use integrative medicine strategy to ease physical or mental health symptoms

People who use high potency cannabis more likely to experience addiction, psychotic disorder

Religious leaders can be effective change agents for reducing intimate partner violence

Dental health care workers report anxiety and depression symptoms during peaks of the pandemic

What is the role of psychedelic drugs in the treatment of psychiatric disorders?

High-dose supplementation of Vitamin B6 decreases anxiety

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

Research highlights the impact of social determinants of health on hypertension control

Wearable activity trackers are effective in increasing physical activity and improving health

Review: No clear evidence that serotonin levels are responsible for depression

Fatigue in long covid patients linked to anxiety, depression, and apathy

High-dose Vitamin B6 tablets could reduce feelings of anxiety and depression

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Depression News and Research

Latest Depression News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in